Published in Gastrointest Endosc on February 01, 2007
Comparing Anesthetic Techniques in Children Having Esophagogastroduodenoscopies | NCT02038894
Indicators of safety compromise in gastrointestinal endoscopy. Can J Gastroenterol (2012) 1.30
Anesthesia and sedation in pediatric gastrointestinal endoscopic procedures: A review. World J Gastrointest Endosc (2010) 0.95
Diagnostic yield of EGD in children: a retrospective single-center study of 1000 cases. Gastrointest Endosc (2013) 0.87
Endoscopy Following Pediatric Intestinal Transplant. J Pediatr Gastroenterol Nutr (2015) 0.85
Therapeutic upper gastrointestinal tract endoscopy in Paediatric Gastroenterology. World J Gastrointest Endosc (2015) 0.82
Western view of the management of gastroesophageal foreign bodies. World J Gastrointest Endosc (2016) 0.78
The concordance of endoscopic and histologic findings of 1000 pediatric EGDs. Gastrointest Endosc (2014) 0.78
Sex, psychosocial factors, and reported symptoms influence referral for esophagogastroduodenoscopy and biopsy results in children with chronic abdominal pain. J Pediatr Gastroenterol Nutr (2008) 0.77
Efficiency of upper gastrointestinal endoscopy in pediatric surgical practice. World J Clin Pediatr (2015) 0.77
Clinical effectiveness of an anesthesiologist-administered intravenous sedation outside of the main operating room for pediatric upper gastrointestinal endoscopy in Thailand. Int J Pediatr (2010) 0.76
Comparison of performance and safety of endoscopic retrograde cholangiopancreatography across pediatric age groups. Dig Dis Sci (2013) 0.76
Diagnosing native liver fibrosis and esophageal varices using liver and spleen stiffness measurements in biliary atresia: a pilot study. Pediatr Radiol (2016) 0.76
Clinical value of wireless pH-monitoring of gastro-esophageal reflux in children before and after proton pump inhibitors. BMC Gastroenterol (2014) 0.75
Disaccharidase activity in children undergoing esophagogastroduodenoscopy: A systematic review. World J Gastrointest Pharmacol Ther (2016) 0.75
Complications of Endoscopic Retrograde Cholangiopancreatography in Pediatric Patients; A Systematic Literature Review and Meta-Analysis. J Pediatr (2016) 0.75
Advanced Monitoring Is Associated with Fewer Alarm Events During Planned Moderate Procedure-Related Sedation: A 2-Part Pilot Trial. Anesth Analg (2016) 0.75
Complications of pediatric EGD: more questions than answers... Gastrointest Endosc (2007) 0.75
Propofol Use in Pediatric Patients With Food Allergy and Eosinophilic Esophagitis. J Pediatr Gastroenterol Nutr (2016) 0.75
Gastroscopy in pediatric surgery: indications, complications, outcomes, and ethical aspects. Gastroenterol Res Pract (2015) 0.75
Interfaces in Pediatric Gastrointestinal Endoscopy: Who Should Do It? Visc Med (2016) 0.75
The value of Integrated Pulmonary Index (IPI) monitoring during endoscopies in children. J Clin Monit Comput (2015) 0.75
Predictors of positive esophagogastroduodenoscopy outcomes in children and adolescents: a single center experience. BMC Res Notes (2017) 0.75
Esophageal carcinoma. N Engl J Med (2014) 5.77
The epidemiology of cholangiocarcinoma. Semin Liver Dis (2004) 5.59
Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States. Ann Intern Med (2011) 4.98
The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol (2005) 4.96
Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med (2005) 4.52
Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol (2004) 4.39
Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology (2010) 3.98
Obesity: a challenge to esophagogastric junction integrity. Gastroenterology (2006) 3.72
Norwalk virus shedding after experimental human infection. Emerg Infect Dis (2008) 3.70
Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr (2005) 3.37
Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology (2004) 3.30
Risk factors for cholangiocarcinoma. Hepatology (2011) 3.27
Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology (2005) 3.24
Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology (2011) 3.24
Epidemiology of hepatocellular carcinoma: consider the population. J Clin Gastroenterol (2013) 3.12
The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis (2010) 2.96
Gaps in the achievement of effectiveness of HCV treatment in national VA practice. J Hepatol (2011) 2.96
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol (2007) 2.90
Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol (2013) 2.89
Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc (2007) 2.77
Cost-effectiveness and diagnostic effectiveness analyses of multiple algorithms for the diagnosis of Lynch syndrome. Dig Dis Sci (2014) 2.77
Utilization of screening for hepatocellular carcinoma in the United States. J Clin Gastroenterol (2007) 2.73
Intelligent Systems For Assessing Aging Changes: home-based, unobtrusive, and continuous assessment of aging. J Gerontol B Psychol Sci Soc Sci (2011) 2.71
Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002. Am J Gastroenterol (2007) 2.69
Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. Gastroenterology (2010) 2.64
Missed opportunities to initiate endoscopic evaluation for colorectal cancer diagnosis. Am J Gastroenterol (2009) 2.60
Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis (2013) 2.50
Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males. Hepatology (2011) 2.42
Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin Gastroenterol Hepatol (2012) 2.25
The epidemiology of obesity. Gastroenterol Clin North Am (2010) 2.23
Serological correlate of protection against norovirus-induced gastroenteritis. J Infect Dis (2010) 2.21
Utilization of upper endoscopy for surveillance of gastric ulcers in the United States. Am J Gastroenterol (2008) 2.14
Evaluation for liver transplantation: adherence to AASLD referral guidelines in a large Veterans Affairs center. Liver Transpl (2005) 2.06
Magnet ingestions in children presenting to US emergency departments, 2002-2011. J Pediatr Gastroenterol Nutr (2013) 1.98
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol (2007) 1.96
Is there a true "shift" to the right colon in the incidence of colorectal cancer? Am J Gastroenterol (2003) 1.91
Insurance status and treatment candidacy of hepatitis C patients: analysis of population-based data from the United States. Hepatology (2011) 1.81
Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the American Association for the Study of Liver Diseases. Hepatology (2010) 1.80
Age at onset of GERD symptoms predicts risk of Barrett's esophagus. Am J Gastroenterol (2013) 1.80
Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. J Hepatol (2008) 1.78
A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev (2006) 1.76
The association between Barrett's esophagus and Helicobacter pylori infection: a meta-analysis. Helicobacter (2012) 1.74
Fundoplication and the risk of esophageal cancer in gastroesophageal reflux disease: a Veterans Affairs cohort study. Am J Gastroenterol (2005) 1.72
Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study. Clin Gastroenterol Hepatol (2006) 1.72
The quality of care provided to patients with cirrhosis and ascites in the Department of Veterans Affairs. Gastroenterology (2012) 1.71
Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? Am J Gastroenterol (2003) 1.70
Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001. Arch Intern Med (2004) 1.70
Surgical volume and long-term survival following surgery for colorectal cancer in the Veterans Affairs Health-Care System. Am J Gastroenterol (2004) 1.69
Determinants of medical system delay in the diagnosis of colorectal cancer within the Veteran Affairs Health System. Dig Dis Sci (2010) 1.68
Survival of colorectal cancer patients hospitalized in the Veterans Affairs Health Care System. Am J Gastroenterol (2003) 1.68
Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States. J Clin Gastroenterol (2002) 1.66
Assessment of the quality of colonoscopy reports: results from a multicenter consortium. Gastrointest Endosc (2009) 1.64
The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States. Am J Gastroenterol (2004) 1.62
The prevalence of suspected Barrett's esophagus in children and adolescents: a multicenter endoscopic study. Gastrointest Endosc (2006) 1.60
Statin therapy and serum transaminases among a cohort of HCV-infected veterans. Dig Dis Sci (2010) 1.57
Hepatocellular carcinoma associated with autoimmune hepatitis. J Clin Gastroenterol (2003) 1.56
Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol (2013) 1.56
Risk of colorectal cancer among Caucasian and African American veterans with ulcerative colitis. Inflamm Bowel Dis (2011) 1.53
Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. Gastroenterology (2010) 1.51
Helicobacter pylori-negative gastritis: prevalence and risk factors. Am J Gastroenterol (2012) 1.51
The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C. Am J Gastroenterol (2005) 1.50
HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV. Hepatology (2014) 1.46
Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era. J Hepatol (2005) 1.44
Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men. Clin Gastroenterol Hepatol (2012) 1.41
Association between facility characteristics and the process of care delivered to patients with hepatitis C virus infection. Dig Dis Sci (2013) 1.41
Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann Intern Med (2003) 1.33
An evaluation of endoscopic indications and findings related to nonvariceal upper-GI hemorrhage in a large multicenter consortium. Gastrointest Endosc (2008) 1.32
Medication usage and the risk of neoplasia in patients with Barrett's esophagus. Clin Gastroenterol Hepatol (2009) 1.29
National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs. Gastroenterology (2005) 1.29
Neuropathologic basis of white matter hyperintensity accumulation with advanced age. Neurology (2013) 1.29
Noncardia gastric adenocarcinoma remains an important and deadly cancer in the United States: secular trends in incidence and survival. Am J Gastroenterol (2006) 1.25
Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a HuGE systematic review and meta-analysis. Am J Epidemiol (2007) 1.24
Reducing referral delays in colorectal cancer diagnosis: is it about how you ask? Qual Saf Health Care (2010) 1.23
Prevalence of upper gastrointestinal tract findings in patients with noncardiac chest pain versus those with gastroesophageal reflux disease (GERD)-related symptoms: results from a national endoscopic database. Am J Gastroenterol (2007) 1.22
Serological responses to experimental Norwalk virus infection measured using a quantitative duplex time-resolved fluorescence immunoassay. Clin Vaccine Immunol (2011) 1.20
Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection. Hepatology (2010) 1.20
Gastroesophageal reflux and asthma in children: a systematic review. Pediatrics (2010) 1.18
Age- and sex-specific yield of Barrett's esophagus by endoscopy indication. Gastrointest Endosc (2009) 1.17
Surveillance for hepatocellular carcinoma: development and validation of an algorithm to classify tests in administrative and laboratory data. Dig Dis Sci (2010) 1.16
Oral bisphosphonate prescriptions and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. Dig Dis Sci (2010) 1.16
One walk a year to 1000 within a year: continuous in-home unobtrusive gait assessment of older adults. Gait Posture (2011) 1.16
Patient-centered, comparative effectiveness of esophageal cancer screening: protocol for a comparative effectiveness research study to inform guidelines for evidence-based approach to screening and surveillance endoscopy. BMC Health Serv Res (2012) 1.15
Psychosocial factors are the most common contraindications for antiviral therapy at initial evaluation in veterans with chronic hepatitis C. J Clin Gastroenterol (2004) 1.15
Underdiagnosis of Lynch syndrome involves more than family history criteria. Clin Gastroenterol Hepatol (2010) 1.14
Determinants of serum alpha-fetoprotein levels in hepatitis C-infected patients. Clin Gastroenterol Hepatol (2011) 1.14
Increased esophageal regulatory T cells and eosinophil characteristics in children with eosinophilic esophagitis and gastroesophageal reflux disease. Ann Clin Lab Sci (2009) 1.14
Choosing Wisely and the perceived drivers of endoscopy use. Clin Gastroenterol Hepatol (2013) 1.13
Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era. J Clin Oncol (2008) 1.12
The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias? Am J Gastroenterol (2003) 1.12
Comparison of morning versus afternoon cecal intubation rates. BMC Gastroenterol (2007) 1.11
Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics. Contemp Clin Trials (2012) 1.10
Serum hemagglutination inhibition activity correlates with protection from gastroenteritis in persons infected with Norwalk virus. Clin Vaccine Immunol (2011) 1.10
Utilization and outcomes of palliative therapy for hepatocellular carcinoma: a population-based study in the United States. J Clin Gastroenterol (2012) 1.10
Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage, treatment received, and survival. Clin Gastroenterol Hepatol (2007) 1.07
Natural history of pediatric-onset inflammatory bowel disease: a systematic review. J Clin Gastroenterol (2012) 1.05
Ketamine and midazolam sedation for pediatric gastrointestinal endoscopy in the Arab world. World J Gastroenterol (2011) 1.05
Efficacy, effectiveness, and comparative effectiveness in liver disease. Hepatology (2010) 1.04
Importance of patient, provider, and facility predictors of hepatitis C virus treatment in veterans: a national study. Am J Gastroenterol (2010) 1.03
A closer look at same-day bidirectional endoscopy. Gastrointest Endosc (2008) 1.02